GLP-1-medicijnen veroorzaken onverwachte daling voedselconsumptie in Amerika

GLP-1 weight-loss medications are reshaping American food consumption patterns with significant climate implications. As adoption among U.S. adults has doubled to roughly one in eight people, these drugs are achieving what climate policies haven't: a substantial voluntary decrease in carbon-intensive food demand.